NCT06231849View on ClinicalTrials.gov

Gut Microbiota Dysbiosis in Opioid Use Disorders: Implications for Clinical Symptoms and Relapse Rate.

Not yet recruitingOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

April 30, 2026

Conditions
Opioid UseOpioid Use DisorderOpioid Dependence
Interventions
DIAGNOSTIC_TEST

stool analysis

stool analysis to determine number of gut microbiota in subjects with opioid use and its effect on its intoxication.

All Listed Sponsors
lead

Assiut University

OTHER

NCT06231849 - Gut Microbiota Dysbiosis in Opioid Use Disorders: Implications for Clinical Symptoms and Relapse Rate. | Biotech Hunter | Biotech Hunter